Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,640 | 5,906 | 5,022 | 10,242 | 9,276 |
| Receivables | 1,315 | 224 | 226 | 188 | 202 |
| TOTAL | $5,472 | $6,755 | $5,936 | $10,916 | $9,919 |
| Non-Current Assets | |||||
| PPE Net | 280 | 320 | 357 | 392 | 430 |
| Intangibles | 65,195 | 65,195 | 65,195 | 65,195 | 65,195 |
| Other Non-Current Assets | 53,936 | 148,631 | 148,660 | 148,665 | 148,686 |
| TOTAL | $119,411 | $214,146 | $214,212 | $214,252 | $214,311 |
| Total Assets | $124,883 | $220,901 | $220,148 | $225,168 | $224,230 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 563 | 1,243 | 1,514 | 3,084 | 2,585 |
| Other current liabilities | 1,476 | 1,907 | 1,869 | 2,807 | 4,115 |
| TOTAL | $2,039 | $3,150 | $3,383 | $5,891 | $6,700 |
| Non-Current Liabilities | |||||
| TOTAL | $20,525 | $49,929 | $49,932 | $49,934 | $49,936 |
| Total Liabilities | $22,564 | $53,079 | $53,315 | $55,825 | $56,636 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 59,476 | 59,479 | 58,664 | 58,664 | 58,643 |
| Common Shares | 24 | 714 | 704 | 704 | 694 |
| Retained earnings | -137,430 | -71,676 | -69,795 | -66,568 | -62,556 |
| TOTAL | $102,319 | $167,822 | $166,833 | $169,343 | $167,594 |
| Total Liabilities And Equity | $124,883 | $220,901 | $220,148 | $225,168 | $224,230 |